Wayne DeVeydt's Sale of 30,948 Surgery Partners Shares via Form 144

This SEC Form 144 filing discloses former director Wayne DeVeydt's planned sale of 30,948 common shares of Surgery Partners, Inc. acquired through equity compensation. The filing reveals an extensive pattern of stock dispositions occurring between August and October 2025, with 25 separate transactions totaling approximately $15.6 million in gross proceeds. Notable sales include 100,000 shares sold on August 21 ($2.3M) and 150,000 shares sold on September 18 ($3.3M). The securities were sold through UBS Financial Services Inc. on NASDAQ, with DeVeydt maintaining 128,209,410 shares outstanding post-transactions. As a Form 144 filing, this indicates the sale of restricted or control securities in compliance with SEC regulations.